Tamoxifen for breast cancer: Associated endometrial cancer
Author:
- S. B. GusbergSGS. B. Gusberg
Open Access
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Christie hospital adjuvant tamoxifen trial – status at 10 yearsBritish Journal of Cancer, 1988
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- Endocrine Effects of Tamoxifen in Postmenopausal Breast Cancer PatientsTumori Journal, 1984
- Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer PatientsOncology, 1981
- CANCER OF THE UTERINE CORPUS AFTER HORMONAL TREATMENT FOR BREAST CANCERThe Lancet, 1976
- Increased Risk of Endometrial Carcinoma among Users of Conjugated EstrogensNew England Journal of Medicine, 1975
- Association of Exogenous Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1975
- Precursors of Corpus Carcinoma Estrogens and Adenomatous HyperplasiaAmerican Journal of Obstetrics and Gynecology, 1947